ARCHIVES

NCI Criticized For Delays In Development Of New Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | January 24, 1975

Download PDF Visit The Full Archive

Related Articles

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

May 9, 1997

Univ. Of Pittsburg Vows To Make Changes To Keep NSABP

April 8, 1994

VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds

July 25, 2008

NCI Still Trying To Broaden Group B Drug Distribution

May 5, 1978

NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It

January 24, 1986